HOME >> BIOLOGY >> NEWS
A close-up on pancreatic disease: How do we improve the odds?

WASHINGTON, D.C. (May 24, 2007) � Pancreatic cancer is among the deadliest of today's cancers due to limited tools for early diagnosis and few effective treatments. Research presented today at Digestive Disease Week� 2007 (DDW�) takes a closer look at pancreatic cancer and the conditions that may lead to it, such as chronic pancreatitis, to evaluate the progress made to date, as well as the promising new applications of technology that will improve survival rates in the coming years. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

"We are confident that better technological resources and more clinical trials like those presented today will help us better manage pancreatic disease," said Mark Callery, M.D., FACS, of Harvard Medical School and Beth Israel Deaconess Medical Center. "In particular, we are hoping that these studies will eventually lead the community to more accurate, cost-effective tools for screening, early diagnosis and successful treatments."

Risk of Malignancy in Resected Cystic Tumors of the Pancreas <3 cm in Size: Is it Safe to Observe Asymptomatic Patients" A Multi-Institutional Report (Abstract #278)

Surgeons and gastroenterologists often use the size of a discovered cystic tumor as a parameter for their treatment decisions; the smaller the size, the less likely they are to take immediate invasive action. But especially in pancreatic cancer, when tumors can grow aggressively, it is critically important to watch for any signs of growth or change. Recent international guidelines have suggested that all cystic pancreatic tumors less than three centimeters (cm) in asymptomatic patients with no radiographic features concerning for malignancy are safe to observe, but there is little published data supporting this guideline.

This study reviewed the incidence of malignancy in small tumors
'"/>

Contact: Aimee Frank
AFrank@gastro.org
301-941-2620
American Gastroenterological Association
22-May-2007


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. COX-2 inhibitors delay pancreatic cancer precursors in mice
2. Skin rash actually signifies better outcomes for pancreatic and lung cancer patients
3. Cell receptor may lead to new biomarker for pancreatic cancer
4. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
5. Dietary vitamin B6, B12 and folate, may decrease pancreatic cancer risk among lean people
6. Popular herbal supplement hinders the growth of pancreatic cancer cells
7. Research strengthens link between smoking, pancreatic cancer
8. Scientists identify pancreatic cancer stem cells
9. U-M researchers identify stem cells in pancreatic cancer
10. Micro molecules can identify pancreatic cancer
11. University of Washington-led team discovers a gene that causes familial pancreatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... 2020 , ... Mosio recently announced its newly updated text ... of all sizes. With a focus on tracking symptoms and monitoring outbreaks as ... Mosio helps public health departments automate communications and provide more personalized care and ...
(Date:8/3/2020)... ... 03, 2020 , ... Accumen Inc. is helping healthcare get ... Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. , “Accumen has ... than 10 years. Early in the COVID-19 crisis, we identified supply chain gaps ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device ... The study reported that the Neoasis™ device attenuated the alarm sounds from patient ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:7/31/2020)... , ... July 29, 2020 , ... R3 Stem Cell ... for only $3950. With 50 million stem cells total, patients may choose which extremities ... therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord ...
(Date:7/31/2020)... N.J (PRWEB) , ... July 29, 2020 , ... ... company, and Catalent, the leading global provider of advanced delivery technologies, development, and ... today announced that they have entered into a strategic partnership whereby Catalent will ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
Breaking Biology Technology:
Cached News: